Jyong Biotech Ltd
Research Jyong Biotech Ltd (MENS) on Bullrun: market cap USD 163.31M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMENS
- ExchangeNASDAQ
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 163.31M
- Financial periodFY2025
- Net income-USD 4.67M
Valuation Snapshot
latest market cap is USD 163.31M.
About Jyong Biotech Ltd
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome.
Frequently asked questions
What is Jyong Biotech Ltd's market cap?
Jyong Biotech Ltd's market capitalization is USD 163.31M.
What does Jyong Biotech Ltd do?
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.